Biomarkers to Detect Mesothelioma Early in Patients Exposed to Asbestos or Vermiculite

Completed

Conditions studied: Malignant Mesothelioma, Pulmonary Complications

In brief

RATIONALE: Studying samples of body fluid and blood from patients who have been exposed to asbestos or vermiculite in the laboratory may help doctors learn more about changes that may occur in DNA and identify biomarkers related to cancer. PURPOSE: This laboratory study is looking for biomarkers to detect mesothelioma early in patients exposed to asbestos or vermiculite.

Key facts

Study ID
NCT00897247
Run by
Barbara Ann Karmanos Cancer Institute
People needed
494
Starts
2007-01-01
Expected to finish
2013-10-01
Last updated by the study team
2014-03-05

Who can join

Age: 25 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.